S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL. (23rd June 2022) - Russell, N.; Wilhelm-Benartzi, C.; Knapper, S.; Batten, L.; Canham, J; Hinson, E.; Malthe Overgaard, U.; Othman, J.; Dillon, R.; Mehta, P.; Kottaridis, P.; Cavenagh, J.; et al.